IQVIA tops Q3 expectations, reaffirms full-year outlook By Investing.com
Update: 2025-10-28
Description
IQVIA Holdings, a clinical research and healthcare intelligence company, reported robust Q3 results, with a 5% increase in revenue to $4.1 billion and adjusted earnings per share of $3, surpassing analyst predictions. All business segments showed growth, with Technology and Analytics Solutions up 5% and Research and Development Solutions up 4.5%. Net income reached $331 million, and free cash flow surged by 35% to $772 million. The company's strong demand for R&D Solutions and healthy contracted backlog indicate a promising pipeline of projects. IQVIA reaffirmed their full-year guidance, projecting revenue between $16.15 billion and $16.25 billion and adjusted earnings per share between $11.85 and $11.95.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
